Skip to content

Study to evaluate the efficacy and safety of Nutricharge Gainer with Nutricharge Prodiet on improved muscle mass

Randomized, Single centric, single arm, open label study to evaluate the efficacy and safety of Nutricharge Gainer with Nutricharge Prodiet on improved muscle mass along with increased energy levels

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2017/11/010493
Enrollment
50
Registered
2017-11-15
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Intervention1: Nutricharge Gainer with Nutricharge Prodiet: Nutricharge Gainer with Nutricharge Prodiet. Take one scoop (20g) of Nutricharge Gainer and one scoop (20g) of Nutricharge Prodiet with 2

Sponsors

Trophic Wellness Pvt Ltd
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Male subjects between 18-60 years of age 2.Subjects able to communicate effectively. 3.Subjects willing to provide written informed consent 4.In the judgment of the Principal Investigator, able to comply with protocol requirements. 5.Ability to schedule and attend monthly visits for the duration of the study. 6.Agree to do physical activities as stated in the protocol 7.Subject agrees not to start any new supplement which would affect body composition during the course of the study

Exclusion criteria

Exclusion criteria: 1.Contraindications or Hypersensitivity to study product. 2.History or presence of any medical condition or disease according to the discretion of the Investigator. 3.No contraindications to exercise as outlined by the American College of Sports Medicine (ACSM). 4.Use of nutritional supplements known to improve energy and muscle strength and/or muscle mass within seven weeks prior to the start of the study. 5.All medications that can interfere with muscle mass such as corticosteroids (e.g. Prednisone), testosterone replacement or anabolic drugs. 6.Subjects who are under herbal supplements within seven (7) days prior to screening. 7.Subjects using any other therapies that would affect body composition other than those revealed during recruitment process. 8.Subjects having history of asthma. 9.Subjects having history of cardiovascular diseases. 10.Subjects having history of diabetes (Type I or Type II) except other than the subject having the pre-diabetes condition with the fasting blood glucose between 100 to 125 mg/dl or random blood glucose > 140-199 mg/dl. 11.Subjects having BP above 180/100 or below 80/50 mmHg 12.Subjects having thyroid disease. 13.Subjects having abnormal liver or kidney function tests (ALT or AST 2 times the upper limit of normal; elevated Creatinine, males 125 μmol/L,). 14.Subjects having abnormal findings on complete blood count 15.Subjects with HIV Positive. 16.Subjects having history of high alcohol intake (2 standard drinks per day). 17.Subjects having history of psychiatric disorder that may impair the ability of subjects to provide written informed consent. 18.Any other condition that, in the opinion of the investigator, would adversely affect the subjectâ??s ability to complete the study or its measures. 19.Subjects participated in any clinical study within thirty (30) days prior to screening.

Design outcomes

Primary

MeasureTime frame
Improved muscle mass along with increased energy levels in healthy adults.Timepoint: 30 days, 60 days & 90 days

Secondary

MeasureTime frame
1.To assess the safety and tolerability of Nutricharge Gainer with Nutricharge Prodiet on improved muscle mass along with increased energy levels in healthy adults. 2.To identify the change in quality of life by using Health Related Quality of Life questionnaire (HRQOL- SF-36). Timepoint: 30 days, 60 days & 90 days

Countries

India

Contacts

Public ContactDr D M Ravichand

Trophic Wellness Pvt Ltd

vveda14@gmail.com7702188849

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026